Data as of Mar 07
| +0.53 / +0.77%|
The 6 analysts offering 12-month price forecasts for Ligand Pharmaceuticals Inc have a median target of 91.50, with a high estimate of 96.00 and a low estimate of 44.00. The median estimate represents a +31.13% increase from the last price of 69.78.
The current consensus among 6 polled investment analysts is to Buy stock in Ligand Pharmaceuticals Inc. This rating has held steady since February, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.